Literature DB >> 8608640

Detection of hepatitis C virus (HCV) proteins by immunofluorescence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow and peripheral blood mononuclear cells of chronically HCV-infected patients.

D Sansonno1, A R Iacobelli, V Cornacchiulo, G Iodice, F Dammacco.   

Abstract

Immunofluorescence (IF) to detect HCV antigens and non-isotopic in situ hybridization (NISH) to detect HCV RNA genome were carried out on bone marrow (BM) and peripheral blood (PB) mononuclear cells (MC) of 11 chronically HCV-infected patients. In four patients (36.4%) HCV antigens were detected in monocytes/macrophages as well as in B lymphocytes in both BMMC and PBMC. Positive T lymphocytes in BMMC were found in three of them, but only one patient showed positive T cells in PBMC. NISH invariably demonstrated minus and plus HCV RNA genomic strands either in monocytes/macrophages or B and T lymphocytes in BMMC and PBMC in the four HCV antigen-positive patients and in two further patients not expressing viral proteins in blood MC. IF signals appeared diffusely distributed within the cytoplasm, or as brilliant granules in distinct submembrane areas or else in cytoplasm membrane. Nuclei never stained. Similarly, NISH displayed HCV RNA accumulation restricted to MC cytoplasm only, nuclei being persistently negative. NISH, however, was unable to detect cell membrane signal. Infection of blood MC is a common event in naturally acquired HCV infection, since none of these patients was conditioned by immunomodulating or immunosuppressive therapies. No difference was found in terms of age, length of disease, anti-HCV immune response, type and severity of chronic liver damage between patients with HCV-infected MC and patients without cell infection. These results demonstrate that HCV can infect BMMC and PBMC that represent important extrahepatic sites of virus replication, and may help to explain the immunological abnormalities observed in chronic HCV carriers.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8608640      PMCID: PMC2200370          DOI: 10.1111/j.1365-2249.1996.tb08296.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  46 in total

1.  Purification of human T and B cells by a discontinuous density gradient of percoll.

Authors:  C Gutierrez; R R Bernabe; J Vega; M Kreisler
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

Review 2.  To C or not to C: these are the questions.

Authors:  H J Alter
Journal:  Blood       Date:  1995-04-01       Impact factor: 22.113

3.  Hepatitis C virus and autoimmunity: fortuitous association or reality?

Authors:  F Lunel
Journal:  Gastroenterology       Date:  1994-11       Impact factor: 22.682

4.  Antibodies to hepatitis C virus in non-A, non-B post-transfusion and cryptogenetic chronic liver disease.

Authors:  D Sansonno; F Dammacco
Journal:  Lancet       Date:  1989-09-30       Impact factor: 79.321

5.  Kinetics of anti-hepatitis C virus response during acute hepatitis in an immunosuppressed HCV chronically infected patient.

Authors:  D Sansonno; P Procaccio; F Dammacco
Journal:  Digestion       Date:  1991       Impact factor: 3.216

Review 6.  Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis.

Authors:  Q L Choo; A J Weiner; L R Overby; G Kuo; M Houghton; D W Bradley
Journal:  Br Med Bull       Date:  1990-04       Impact factor: 4.291

7.  Identification and characterization of type 2 dengue virus replicative intermediate and replicative form RNAs.

Authors:  G R Cleaves; T E Ryan; R W Schlesinger
Journal:  Virology       Date:  1981-05       Impact factor: 3.616

8.  Antibody-enhanced dengue virus infection in primate leukocytes.

Authors:  S B Halstead; E J O'Rourke
Journal:  Nature       Date:  1977-02-24       Impact factor: 49.962

9.  Detection of hepatitis C virus RNA in peripheral blood mononuclear cells of infected patients by in situ hybridization.

Authors:  J Moldvay; P Deny; S Pol; C Brechot; E Lamas
Journal:  Blood       Date:  1994-01-01       Impact factor: 22.113

10.  Failure to detect hepatitis C virus (HCV) genome by polymerase chain reaction in human anti-HCV-positive intravenous immunoglobulins.

Authors:  F Dammacco; D Sansonno; A Beardsley; E J Gowans
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

View more
  23 in total

1.  HCV-RNA positivity in peripheral blood mononuclear cells of patients with chronic HCV infection: does it really mean viral replication?

Authors:  V Meier; S Mihm; P Braun Wietzke; G Ramadori
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Flow cytometric detection of hepatitis C virus antigens in infected peripheral blood leukocytes: binding and entry.

Authors:  Mostafa K el-Awady; Ashraf A Tabll; el-Rashdy M Redwan; Samar Youssef; Moataza H Omran; Fouad Thakeb; Maha el-Demellawy
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

3.  Hepatitis C virus productive infection in mononuclear cells from patients with cryoglobulinaemia.

Authors:  D Sansonno; F A Tucci; G Lauletta; V De Re; M Montrone; L Troiani; L Sansonno; F Dammacco
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 4.  Mixed cryoglobulinemia as a model of systemic vasculitis.

Authors:  F Dammacco; D Sansonno
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

5.  Extra-hepatic infection of hepatitis C virus in the colon tissue and its relationship with hepatitis C virus pathogenesis.

Authors:  Helal F Hetta; Mohamed A Mekky; Nasr K Khalil; Wegdan A Mohamed; Mohamed A El-Feky; Shabaan H Ahmed; Enas A Daef; Ahmed Medhat; Mahmoud I Nassar; Kenneth E Sherman; Mohamed Tarek M Shata
Journal:  J Med Microbiol       Date:  2016-05-10       Impact factor: 2.472

6.  Use of whole blood specimens for routine clinical quantitation of hepatitis C virus RNA does not increase assay sensitivity.

Authors:  L Cook; A M Ross; G B Knight; V Agnello
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

7.  Histological characterization of HCV-associated glomerulopathy in Egyptian patients.

Authors:  Alaa Sabry; Amgad El-Agroudy; Hussein Sheashaa; Amr El-Husseini; Nohir Mostafa Taha; Mahmoud Elbaz; Fagr El-Shahat; Mohamed Sobh
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

8.  HCV replication in PBMC and its influence on interferon therapy.

Authors:  Guo-Zhong Gong; Li-Ying Lai; Yong-Fang Jiang; Yan He; Xian-Shi Su
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

9.  Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid.

Authors:  Tomasz Laskus; Marek Radkowski; Agnieszka Bednarska; Jeffrey Wilkinson; Debra Adair; Marek Nowicki; Georgia B Nikolopoulou; Hugo Vargas; Jorge Rakela
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 10.  Role of macrophages and monocytes in hepatitis C virus infections.

Authors:  Dennis Revie; Syed Zaki Salahuddin
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.